SCHEMBL2916138

SCHEMBL2916138

O=CCc1ccccc1Nc1nc(Cl)ncc1Cl

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 1/20 0.39
ULK1 O75385 1/20 0.39
MAPK8 P45983 1/20 0.38
CDK9 P50750 5/20 0.38
CCNA2 P20248 3/20 0.38
CDK2 P24941 3/20 0.38
CCNK O75909 2/20 0.38
CCND3 P30281 2/20 0.38
CDK6 Q00534 2/20 0.38
MAPK9 P45984 2/20 0.38
MAPK10 P53779 2/20 0.38
AURKA O14965 1/20 0.38
BCL6 P41182 1/20 0.38
MAPT P10636 1/20 0.37
MAPK3 P27361 3/20 0.36
PIN1 Q13526 1/20 0.36
LRRK2 Q5S007 1/20 0.36
CDK7 P50613 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176285 0.87 IGF1R (0.48) ALKMAPK8CDK2MAPK9MAPK10
SCHEMBL6178375 0.83 PIN1 (0.60) MAPTPIN1
SCHEMBL2061884 0.82 BPTF (0.44) ALKULK1MAPK8CDK9CCNA2
SCHEMBL2060756 0.80 LRRK2 (0.43) ALKULK1MAPK8CDK9CCNA2
SCHEMBL30833643 0.79 ALK (0.43) ALKMAPK8CDK9MAPK9MAPK10
SCHEMBL29904714 0.79 ALK (0.48) ALKULK1MAPK8CDK9CCNA2
SCHEMBL30833627 0.79 BCL6 (0.39) ALKULK1MAPK8CDK9CCNA2
SCHEMBL26906809 0.79 ALK (0.48) ALKULK1MAPK8CDK9CCNA2
SCHEMBL18812831 0.78 CCNA2 (0.41) ALKULK1MAPK8CDK9CCNA2
SCHEMBL2062564 0.78 IGF1R (0.54) ALKULK1CDK9CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222647-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS Cephalon, Inc. (US) 2010-09-01 EP disclosed
WO-2008051547-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON, INC. (US) 2008-05-02 WO disclosed